HK Stock Market Move | Jl Mag Rare-Earth(06680) rose over 4% as industrial demand drove improvement in supply and demand of rare earths. Institutions are optimistic about prices continuing to rise this year.
Jinli Permanent Magnet (06680) rose more than 4%, as of the time of writing, it rose by 4.01%, to HK$7.79, with a trading volume of HK$35.2248 million.
Jl Mag Rare-Earth (06680) surged over 4%, rising by 4.01% to HK$7.79 at the time of writing, with a turnover of HK$35.2248 million.
In terms of news, Sinolink pointed out that as a leading industry in China with widespread pricing and downstream applications, rare earths are expected to attract significant attention in the context of the change of government in the United States. It reiterated the opportunity for value reassessment brought about by the upward trend of the basic fundamentals of rare earth stocks, the catalytic effect of the "similar supply reform" policy, and the status as a "big country weapon"; the magnetic plate benefits from the humanoid Siasun Robot & Automation and the strong growth in the low-altitude economy. It suggests paying attention to Jl Mag Rare-Earth (a leading company in high-end magnetic materials, positioning in humanoid Siasun Robot & Automation), among others.
HAITONG INT'L stated that since the second half of 2024, the supply of rare earths has been tightening, with a significant decline in the growth rate of domestic rare earth supply indicators in 2024, and frequent disruptions in overseas rare earth production and imports. The implementation of the "Rare Earth Management Regulations" further strengthens supply constraints. In the fourth quarter of 2024, rare earth prices rebounded, with the average price of praseodymium-neodymium oxide reaching 416,000 yuan per ton, a quarter-on-quarter increase of 7.1%. The bank believes that driven by the demand from industries such as new energy vehicles and wind power, the supply and demand pattern of rare earths will continue to improve, and rare earth prices are expected to continue to rise in 2025.
Related Articles

Anhui Hengyuan Coal Industry and Electricity Power (600971.SH) plans to acquire 100% equity of Hongneng Coal Industry and Changsheng Energy, increasing its resource reserves.

Subsidiary YKYY013 injection of Youcare Pharmaceutical Group (688658.SH) approved for clinical trials.

Fuan Pharmaceutical (300194.SZ) subsidiary received the Philippines GMP compliance certificate.
Anhui Hengyuan Coal Industry and Electricity Power (600971.SH) plans to acquire 100% equity of Hongneng Coal Industry and Changsheng Energy, increasing its resource reserves.

Subsidiary YKYY013 injection of Youcare Pharmaceutical Group (688658.SH) approved for clinical trials.

Fuan Pharmaceutical (300194.SZ) subsidiary received the Philippines GMP compliance certificate.

RECOMMEND

World’s largest oil company Aramco posts higher Q3 net profit after lifting output
04/11/2025

HSBC, General Atlantic CEOs flag AI capex-revenue mismatch, ‘irrational exuberance’
04/11/2025

Pfizer Files Second Lawsuit Against Novo Nordisk and Metsera Amid Intensifying Bidding Battle Over Obesity Biotech
04/11/2025


